NDC - HCPCS Crosswalk

Effective January 1, 2019 through March 31, 2019

The crosswalk is intended to help understand which drug products -identified by NDCs- are assigned to which HCPCS billing codes. The crosswalk is not intended to be a comprehensive list of all NDCs available in the United States. The NDC to HCPCS Crosswalk also includes information on the NDC package size and the number of billable units.

NDC HCPCS Code Labeler Drug Name Dosage Package Size Package Quantity Billable Units Billable Units / Pkg
0409-1467-01J2300Pfizer Inc.Inj nalbuphine hydrochloride10 MG102520500
0409-1215-01J2310Pfizer Inc.Inj naloxone hydrochloride1 MG1100.44
0409-1215-25J2310Pfizer Inc.Inj naloxone hydrochloride1 MG1100.44
0409-1219-01J2310Pfizer Inc.Inj naloxone hydrochloride1 MG10254100
0409-1219-25J2310Pfizer Inc.Inj naloxone hydrochloride1 MG10254100
0409-1782-69J2310Pfizer Inc.Inj naloxone hydrochloride1 MG1100.44
0641-6132-25J2310West-Ward Pharmaceuticals CorpInj naloxone hydrochloride1 MG1250.410
17478-041-01J2310AkornInj naloxone hydrochloride1 MG1100.44
17478-042-10J2310AkornInj naloxone hydrochloride1 MG10144
67457-292-02J2310Mylan InstitutionalInj naloxone hydrochloride1 MG1100.44
67457-299-10J2310Mylan InstitutionalInj naloxone hydrochloride1 MG1010440
67457-599-02J2310Mylan InstitutionalInj naloxone hydrochloride1 MG1100.44
65757-300-01J2315Alkermes, Inc.Naltrexone, depot form1 MG11380380
64406-008-01J2323BiogenNatalizumab injection1 MG151300300
50242-150-01J2350Genentech, Inc.Injection, ocrelizumab, 1 mg1 MG101300300
0078-0647-81J2353Novartis Pharmaceuticals CorporationOctreotide injection, depot1 MG112020
0078-0648-81J2353Novartis Pharmaceuticals CorporationOctreotide injection, depot1 MG113030
0078-0811-81J2353Novartis Pharmaceuticals CorporationOctreotide injection, depot1 MG111010
0078-0818-81J2353Novartis Pharmaceuticals CorporationOctreotide injection, depot1 MG112020
0078-0825-81J2353Novartis Pharmaceuticals CorporationOctreotide injection, depot1 MG113030
0078-0180-01J2354Novartis Pharmaceuticals CorporationOctreotide inj, non-depot25 MCG110220
0078-0181-01J2354Novartis Pharmaceuticals CorporationOctreotide inj, non-depot25 MCG110440
0078-0182-01J2354Novartis Pharmaceuticals CorporationOctreotide inj, non-depot25 MCG11020200
0078-0183-25J2354Novartis Pharmaceuticals CorporationOctreotide inj, non-depot25 MCG514040
0078-0184-25J2354Novartis Pharmaceuticals CorporationOctreotide inj, non-depot25 MCG51200200
0641-6174-10J2354West-Ward Pharmaceuticals CorpOctreotide inj, non-depot25 MCG110220
0641-6175-10J2354West-Ward Pharmaceuticals CorpOctreotide inj, non-depot25 MCG110440
0641-6176-10J2354West-Ward Pharmaceuticals CorpOctreotide inj, non-depot25 MCG11020200
0641-6177-01J2354West-Ward Pharmaceuticals CorpOctreotide inj, non-depot25 MCG514040
0641-6178-01J2354West-Ward Pharmaceuticals CorpOctreotide inj, non-depot25 MCG51200200
0703-3301-04J2354Sicor Pharmaceuticals, Inc.Octreotide inj, non-depot25 MCG125250
0703-3311-04J2354Sicor Pharmaceuticals, Inc.Octreotide inj, non-depot25 MCG1254100
0703-3321-04J2354Sicor Pharmaceuticals, Inc.Octreotide inj, non-depot25 MCG12520500
0703-3333-01J2354Sicor Pharmaceuticals, Inc.Octreotide inj, non-depot25 MCG514040
0703-3343-01J2354Sicor Pharmaceuticals, Inc.Octreotide inj, non-depot25 MCG51200200
25021-451-01J2354Sagent Pharmaceuticals IncOctreotide inj, non-depot25 MCG110220
25021-452-01J2354Sagent Pharmaceuticals IncOctreotide inj, non-depot25 MCG110440
25021-453-01J2354Sagent Pharmaceuticals IncOctreotide inj, non-depot25 MCG11020200
25021-454-05J2354Sagent Pharmaceuticals IncOctreotide inj, non-depot25 MCG514040
25021-455-05J2354Sagent Pharmaceuticals IncOctreotide inj, non-depot25 MCG51200200
63323-365-01J2354Fresenius Kabi USA LLCOctreotide inj, non-depot25 MCG110220
63323-365-04J2354Fresenius Kabi USA LLCOctreotide inj, non-depot25 MCG110220
63323-376-01J2354Fresenius Kabi USA LLCOctreotide inj, non-depot25 MCG110440
63323-376-04J2354Fresenius Kabi USA LLCOctreotide inj, non-depot25 MCG110440
63323-377-01J2354Fresenius Kabi USA LLCOctreotide inj, non-depot25 MCG11020200
63323-377-04J2354Fresenius Kabi USA LLCOctreotide inj, non-depot25 MCG11020200
63323-378-05J2354Fresenius Kabi USA LLCOctreotide inj, non-depot25 MCG514040
63323-379-05J2354Fresenius Kabi USA LLCOctreotide inj, non-depot25 MCG51200200
67457-239-01J2354Mylan InstitutionalOctreotide inj, non-depot25 MCG110220
67457-245-01J2354Mylan InstitutionalOctreotide inj, non-depot25 MCG110440
67457-246-01J2354Mylan InstitutionalOctreotide inj, non-depot25 MCG11020200
50242-040-62J2357Genentech, Inc.Omalizumab injection5 MG113030
0002-7635-11J2358Eli Lilly and CompanyOlanzapine long-acting inj1 MG11210210
0002-7636-11J2358Eli Lilly and CompanyOlanzapine long-acting inj1 MG11300300
0002-7637-11J2358Eli Lilly and CompanyOlanzapine long-acting inj1 MG11405405
0591-3222-47J2360Actavis Pharma, Inc.Orphenadrine injection60 MG210110
0641-6182-10J2360West-Ward Pharmaceuticals CorpOrphenadrine injection60 MG210110
17478-538-02J2360AkornOrphenadrine injection60 MG210110
25021-651-02J2360Sagent Pharmaceuticals IncOrphenadrine injection60 MG210110
0143-9209-10J2400West-Ward Pharmaceuticals CorpChloroprocaine hcl injection30 ML20100.6676.67
Page 30